Difference between revisions of "Part:BBa K2500011"
Line 106: | Line 106: | ||
<center> | <center> | ||
<figure> | <figure> | ||
− | <img src="https://static.igem.org/mediawiki/2017/f/fc/T--ETH_Zurich--andgatequation2.png" width=" | + | <img src="https://static.igem.org/mediawiki/2017/f/fc/T--ETH_Zurich--andgatequation2.png" width="80%"> |
</figure> | </figure> | ||
</center> | </center> |
Revision as of 19:56, 1 November 2017
AND Gate B: Synthetic Promoter Responsive to LldR and LuxR
The AND gate integrates two signals, namely the presence of high L-lactate concentrations and high bacterial cell density (qorum sensing) and regulates the effector functions of CATE. It allows our engineered bacteria to autonomously decide whether they are currently located in tumor tissue or not.
In the absence of high concentrations of L-lactate, LldR inhibitor proteins bind to the operator sites O1 and O2 surrounding the pLux promoter leading to the formation of a DNA loop. The pLux promoter is sequestered and inaccessible for transcriptional activation by the quorum sensing components.
All our synthetic AND gates increase the production of sGFP with increasing inducer concentrations. Hence, the highest level of activation coincides with the highest amounts of both inducers. No activation is observed at low and intermediary concentrations of inducers.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Usage and Biology
text
Excessive production of lactate even under normoxic conditions is a common feature of cancer cells due to the well-known Warburg effect, which is why we selected this marker as one of the two inputs integrated by our AND gate. LldP is a L-lactate permease transporting L-lactate across the bacterial membrane. At low lactate concentrations, lldR repressor proteins bind the two operator sequences O1 and O2 surrounding the pLux quorum sensing promoter and oligomerize. The oligomerization of bound lldR proteins leads to the formation of a DNA-loop which sequesters the pLux promoter, making it inaccessible for transcription as depicted in Figure 3.
Input 2: AHL (quorum sensing)
Quorum sensing allows bacteria to restrict the expression of certain genes to high bacterial cell densities. N-Acyl homoserine lactone (AHL) is a bacterial messenger molecule which is constantly produced at very low levels by LuxI, diffuses across cell membranes and binds transcriptional activator LuxR. The higher the cell density, the higher the concentration of AHL present in the surrounding of each cell. The AHL:LuxR complex together activate transcription of genes positioned downstream of pLux.
CATE is encoded in E. coli Nissle which has the intrinsic ability to survive and home in tumors. Therefore, an accumulation of bacteria is expected only within tumor cells which is why we chose cell density as the second input. In addition, the integration of quorum sensing also ensures that a sufficient and therefore deadly amount of bacteria carrying the cytotoxic agent have accumulated within the tumor, lowering the incidences of drug resistance due to the incomplete elimination of the tumor.
In conclusion, a combination of high concentrations of lactate and AHL is a unique molecular pattern that should only occur in tumor tissue and therefore represents the only site which can unlock the full cytotoxic capabilities of CATE.
Genetic design
We reasoned that flanking the plux promoter with O1 and O2 should result in an AND-gate behavior and relied on the previously characterized parts BBa_K1847007 (O1-pconst-O2), BBa_R0062 (plux) and BBa_C0062 (LuxR). In design B of the AND gate, we duplicated the lldR binding sites O1 and O2 in order to achieve a molecular zipper mechanism which would lead to a tighter DNA-loop as more LldR repressors are bound. This design in turn requires even higher, tumor-specific concentrations of L-lactate to completely unzip the loop. The space separating the binding sites and pLux was adapted from BBa_K1847007.
Characterization
We determined the dose-response behavior of our AND gates to the two inducers AHL and L-lactate and in order to assess whether our designs would be capable to distinguish healthy and tumor tissue with respect to lactate and expected AHL concentrations.
Two plasmids, a regulator plasmid and an actuator plasmid encoding AND-gate and sGFP, were transformed into E. coli TOP10 as shown in Figure 5. Exponential-phase cultures were induced in microtiter plates with combinations of 8 different AHL and 8 different L-lactate concentrations and analyzed after 5.5 hours growth in the plate. A detailed protocol is available at Protocols
All our synthetic AND gates increase the production of sGFP with increasing inducer concentrations, whereby AND gate C clearly exhibits the lowest level of leakiness as expected due its molecular zipper. Hence, the highest level of activation coincides with the highest amounts of both inducers. No activation is observed at low and intermediary concentrations of inducers.
Modeling
Given our experimental results, we created a new model which considers the leakiness of both inputs, L-lactate and AHL, separately instead of combining them into a global leakiness.
AND gate activation modelSummary
- Our AND gate promoters allow CATE to distinguish levels of lactate and AHL in healthy tissue to those in tumor tissue
- AND gate C exhibits the lowest leakiness due to its molecular zipper design